Surgical Innovations Group (LSE:SUN) PB Ratio : 0.50 (As of Dec. 12, 2024)

View and export this data going back to 1988. Start your Free Trial

What is Surgical Innovations Group PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-12), Surgical Innovations Group's share price is £0.0055. Surgical Innovations Group's Book Value per Share for the quarter that ended in Jun. 2024 was £0.01. Hence, Surgical Innovations Group's PB Ratio of today is 0.50.

The historical rank and industry rank for Surgical Innovations Group's PB Ratio or its related term are showing as below:

LSE:SUN' s PB Ratio Range Over the Past 10 Years
Min: 0.39 Med: 1.63 Max: 5.31
Current: 0.5

During the past 13 years, Surgical Innovations Group's highest PB Ratio was 5.31. The lowest was 0.39. And the median was 1.63.

LSE:SUN's PB Ratio is ranked better than
94.66% of 787 companies
in the Medical Devices & Instruments industry
Industry Median: 2.34 vs LSE:SUN: 0.50

During the past 3 years, the average Book Value Per Share Growth Rate was -2.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -9.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -4.20% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Surgical Innovations Group was 141.70% per year. The lowest was -68.40% per year. And the median was 8.55% per year.

Back to Basics: PB Ratio

Surgical Innovations Group PB Ratio Historical Data

The historical data trend for Surgical Innovations Group's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgical Innovations Group PB Ratio Chart

Surgical Innovations Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

1.28

1.38

2.14

1.33

0.55

Surgical Innovations Group Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
PB Ratio	Get a 7-Day Free Trial															1.68	1.33	1.73	0.55	0.39

Competitive Comparison of Surgical Innovations Group's PB Ratio

For the Medical Devices subindustry, Surgical Innovations Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Surgical Innovations Group's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's PB Ratio distribution charts can be found below:

* The bar in red indicates where Surgical Innovations Group's PB Ratio falls into.

Surgical Innovations Group PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Surgical Innovations Group's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Jun. 2024)
	=	0.0055	/	0.011
	=	0.50

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Surgical Innovations Group (LSE:SUN) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Surgical Innovations Group PB Ratio Related Terms

Thank you for viewing the detailed overview of Surgical Innovations Group's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Surgical Innovations Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgical Innovations Group PLC (LSE:SUN) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ

Website

https://www.sigroupplc.com

Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and equipment for precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment which derives key revenue, includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The Distribution segment includes the distribution of specialist medical products.